A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis (Q92464692)
Jump to navigation
Jump to search
scientific article published on 15 May 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis |
scientific article published on 15 May 2018 |
Statements
A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis (English)
Annemarie Schorpion
Max Shenin
1 reference